AHR

American Healthcare REIT, Inc. (AHR) - Q2 2025 Filing Summary

Business Context and Reporting Period

This summary covers the Quarterly Report on Form 10-Q for American Healthcare REIT, Inc. for the period ended June 30, 2025. The Company is a self-managed REIT operating a diversified portfolio of clinical healthcare real estate, including Integrated Senior Health Campuses (ISHC), Senior Housing Operating Properties (SHOP), Outpatient Medical (OM) buildings, and triple-net leased properties. As of June 30, 2025, the portfolio consisted of 309 buildings/campuses with approximately 19.2 million square feet of gross leasable area.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 7.5% year-over-year for the three months ended June 30, 2025, and 7.9% for the six-month period. This was driven primarily by increased resident occupancy and higher billing rates in the ISHC and SHOP segments.
• Profitability: Net income attributable to controlling interest improved significantly from $2.0 million (Q2 2024) to $9.9 million (Q2 2025). However, the six-month net income was impacted by a $34.4 million impairment charge on six OM buildings, compared to no impairment in the prior year.
• Debt Reduction: Total debt decreased due to paydowns using proceeds from equity offerings. The Company terminated the Trilogy Credit Facility in March 2025. Outstanding borrowings under the 2024 Credit Facility were $550 million as of June 30, 2025, down from $689 million at year-end 2024.
• Interest Expense: Total interest expense decreased by approximately 23% for the six months ended June 30, 2025, compared to the prior year, primarily due to lower debt balances.

Guidance, Outlook, and Risks

• Capital Markets: The Company completed its At-The-Market (ATM) offering program in July 2025, raising approximately $252 million in gross proceeds during the first half of 2025. A forward sales agreement was settled in July 2025 for an additional $126 million in net proceeds.
• Distributions: The Board authorized a quarterly distribution of $0.25 per share, representing an annualized rate of $1.00 per share.
• Acquisitions & Dispositions: The Company acquired land parcels in Indiana and properties in Indiana and Virginia during the period. It also disposed of six properties (one SHOP, two ISHC, three OM), recognizing a net loss of $3.0 million on dispositions for the six months.
• Risks:
  • Impairment Risk: Continued evaluation of OM buildings led to significant impairment charges in Q2 2025.
  • Regulatory/Tax: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 includes estimated $1 trillion in Medicaid spending cuts, which could adversely impact financial performance. It also permanently extended the 20% deduction for qualified REIT dividends.
  • Interest Rate Risk: While variable-rate debt is hedged via interest rate swaps, the Company remains exposed to market fluctuations.

Investor Verification Checklist

• Impairment Details: Verify the specific operational metrics and fair value assumptions used to justify the $34.4 million impairment charge on OM buildings.
• Medicaid Exposure: Assess the potential impact of the OBBBA Medicaid spending cuts on the Company's ISHC and SHOP segments, which rely on government payors.
• Debt Maturity Profile: Review the maturity schedule for the $1.0 billion in fixed-rate mortgage loans and the $550 million term loan maturing in 2027.
• Occupancy Trends: Confirm the sustainability of the occupancy rate improvements (ISHC at 89.4%, SHOP at 87.0%) driving revenue growth.
• Equity Dilution: Monitor the impact of the completed ATM offering and forward sales agreements on shares outstanding and earnings per share.